SEC Form D · filed August 14, 2012
Immune Response BioPharma, Inc
Offering
$1.0B
Sold
—
Exemption
—
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—
People & firms on this filing (1)
Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗